TOBAM’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Buy |
1,334
+143
| +12% | +$15.3K | 0.06% | 125 |
|
|
2025
Q1 | $120K | Sell |
1,191
-2,974
| -71% | -$300K | 0.05% | 139 |
|
|
2024
Q4 | $372K | Sell |
4,165
-1,256
| -23% | -$112K | 0.11% | 124 |
|
|
2024
Q3 | $454K | Buy |
5,421
+508
| +10% | +$42.5K | 0.08% | 124 |
|
|
2024
Q2 | $378K | Sell |
4,913
-3,721
| -43% | -$286K | 0.06% | 127 |
|
|
2024
Q1 | $591K | Sell |
8,634
-631
| -7% | -$43.2K | 0.05% | 128 |
|
|
2023
Q4 | $536K | Buy |
9,265
+1,585
| +21% | +$91.7K | 0.05% | 126 |
|
|
2023
Q3 | $406K | Hold |
7,680
| – | – | 0.03% | 148 |
|
|
2023
Q2 | $415K | Sell |
7,680
-803
| -9% | -$43.4K | 0.03% | 158 |
|
|
2023
Q1 | $424K | Buy |
8,483
+677
| +9% | +$33.8K | 0.03% | 152 |
|
|
2022
Q4 | $361K | Hold |
7,806
| – | – | 0.02% | 163 |
|
|
2022
Q3 | $302K | Hold |
7,806
| – | – | 0.02% | 178 |
|
|
2022
Q2 | $291K | Buy |
7,806
+819
| +12% | +$30.5K | 0.02% | 208 |
|
|
2022
Q1 | $309K | Buy |
6,987
+2,228
| +47% | +$98.5K | 0.02% | 201 |
|
|
2021
Q4 | $202K | Hold |
4,759
| – | – | 0.01% | 197 |
|
|
2021
Q3 | $206K | Hold |
4,759
| – | – | 0.01% | 194 |
|
|
2021
Q2 | $203K | Buy |
4,759
+2,038
| +75% | +$86.9K | 0.01% | 199 |
|
|
2021
Q1 | $105K | Buy |
2,721
+2,045
| +303% | +$78.9K | ﹤0.01% | 244 |
|
|
2020
Q4 | $24K | Buy |
+676
| New | +$24K | ﹤0.01% | 419 |
|